-
Alarcon J B, Waine G W, McManus D P, 1999: DNA vaccines: technology and application as anti-parasite and anti-microbial agents[J]. Adv Parasitol, 42, 343-410. doi: 10.1016/S0065-308X(08)60152-9
-
Betts M R, Nason M C, West S M, De Rosa S C, Migueles S A, Abraham J, Lederman M M, Benito J M, Goepfert P A, Connors M, Roederer M, Koup R A, 2006: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells[J]. Blood, 107, 4781-4789. doi: 10.1182/blood-2005-12-4818
-
Buchinder S P, Mehrotra D V, Duerr A, Fitzgerald D W, Mogg R, Li D, Gilbert P B, Lama J R, Marmor M, Del Rio C, McElrath M J, Casimiro D R, Gottesdiener K M, Chodakewitz J A, Corey L, Robertson M N; Step Study Protocol Team, 2008: Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-c oncept trial[J]. Lancet, 372, 1881-1893. doi: 10.1016/S0140-6736(08)61591-3
-
Excler J L, Plotkin S, 1997: The prime-boost concept applied to HIV preventive vaccines[J]. AIDS, 11, S127-137.
-
Gu S, Huang T, Miao Y, Ruan L, Zhao Y, Han C, Xiao Y, Zhu J, Wolf H, 1991: A preliminary study on the immunogenicity in rabbits and in human volunteers of a recombinant vaccinia virus expressing Epstein-Barr virus membrane antigen[J]. Chin Med Sci J, 6, 241-243.
-
Guo K J, Ruan L, Wang X J, Yi Y, Liu C B, Ren Y H, Zhang Y C, Liu X H, Gao S J, Yang J W, Zhu J M, 1992: The immunological effect of recombinant vaccinia virus (VMS11HAV25) expressing hepatitis A antigen in humans[J]. Chin J Microbiol Immunol, 12, 137-140.
-
Hel Z, Tsai W P, Thornton A, Nacsa J, Giuliani L, Tryniszewska E, Poudyal M, Venzon D, Wang X, Altman J, Watkins D I, Lu W, von Gegerfelt A, Felber B K, Tartaglia J, Pavlakis G N, Franchini G, 2001: Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen[J]. J Immunol, 167, 7180-7191. doi: 10.4049/jimmunol.167.12.7180
-
Huang X, Xu J, Ren L, Qiu C, Zhang N, Liu L X, Wan Y M, Peng H, Shao Y M, 2006: Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice[J]. Zhonghua Yi Xue Za Zhi, 88, 3109-3113.
-
Ledwith B J, Manam S, Troilo P J, Barnum A B, Pauley C J, Griffiths T G 2nd, Harper L B, Schock H B, Zhang H, Faris J E, Way P A, Beare C M, Bagdon W J, Nichols W W, 2000: Plasmid DNA vaccines: assay for integration into host genomic DNA[J]. Dev Biol (Basel), 104, 33-43.
-
Martin T, Parker S E, Hedstrom R, Le T, Hoffman S L, Norman J, Hobart P, Lew D, 1999: Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection[J]. Dev Biol (Basel), 10, 759-768.
-
Montgomery D L, Ulmer J B, Donnelly J J, Liu M A, 1997: DNA vaccines[J]. Pharmacol Ther, 74, 195-205. doi: 10.1016/S0163-7258(97)82003-7
-
Potter S J, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, Sinet M, Colle J H, Urrutia A, Scott-Algara D, Boufassa F, Delfraissy J F, Thèze J, Venet A, Chakrabarti L A, 2007: Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study[J]. J Virol, 81, 13904-13915. doi: 10.1128/JVI.01401-07
-
Ramshaw I A, Ramsay A J, 2000: The prime-boost strategy: exciting prospects for improved vaccination[J]. Immunol Today, 21, 163-165. doi: 10.1016/S0167-5699(00)01612-1
-
Ren L, Qiu C, Huang X G, Pan X, Xu J Q, Shao Y M, 2006: Construction and immunogenecity analysis of HIV-1 B_ gag-env DNA vaccine[J]. Chin J Microbiol Immunol, 26, 654-658.
-
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil J G, Francis D P, Stablein D, Birx D L, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb M L, Michael N L, Kunasol P, Kim J H; MOPH-TAVEG Investigators, 2009: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand[J]. N Engl J Med, 361, 2209-2220. doi: 10.1056/NEJMoa0908492
-
Robinson H L, Pertmer T M, 2000: DNA vaccines for viral infections: basic studies and applications[J]. Adv Virus Re, 55, 1-74. doi: 10.1016/S0065-3527(00)55001-5
-
Saez-Cirion A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, Barré-Sinoussi F, Delfraissy J F, Sinet M, Pancino G, Venet A, 2007: Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype[J]. Proc Natl Acad Sci U S A, 104, 6776-6781. doi: 10.1073/pnas.0611244104
-
Saez-Cirion A, Sinet M, Shin S Y, Urrutia A, Versmisse P, Lacabaratz C, Boufassa F, Avettand-Fèno?l V, Rouzioux C, Delfraissy JF, Barré-Sinoussi F, Lambotte O, Venet A, Pancino G, 2009: ANRS EP36 HIV Controllers Study Group. 2009. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses[J]. J Immunol, 182, 7828-7837. doi: 10.4049/jimmunol.0803928
-
Schneider J, Gilbert S C, Blanchard T J, Hanke T, Robson K J, Hannan C M, Becker M, Sinden R, Smith G L, Hill A V, 1998: Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara[J]. Nat Med, 4, 397-402. doi: 10.1038/nm0498-397
-
Shiver J W, Fu T M, Chen L, Casimiro D R, Davies M E, Evans R K, Zhang Z Q, Simon A J, Trigona W L, Dubey S A, Huang L, Harris V A, Long R S, Liang X, Handt L, Schleif W A, Zhu L, Freed D C, Persaud N V, Guan L, Punt K S, Tang A, Chen M, Wilson K A, Collins K B, Heidecker G J, Fernandez V R, Perry H C, Joyce J G, Grimm K M, Cook J C, Keller P M, Kresock D S, Mach H, Troutman R D, Isopi L A, Williams D M, Xu Z, Bohannon K E, Volkin D B, Montefiori D C, Miura A, Krivulka G R, Lifton M A, Kuroda M J, Schmitz J E, Letvin N L, Caulfield M J, Bett A J, Youil R, Kaslow D C, Emini E A, 2002: Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency virus immunity[J]. Nature, 415, 331-335. doi: 10.1038/415331a
-
Vilalta A, Mahajan R K, Hartikka J, Rusalov D, Martin T, Bozoukova V, Leamy V, Hall K, Lalor P, Rolland A, Kaslow D C, 2005: I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/ persistence and integration[J]. Hum Gene Ther, 16, 1143-1150. doi: 10.1089/hum.2005.16.1143
-
Wang Z, Troilo P J, Wang X, Griffiths T G, Pacchione S J, Barnum A B, Harper L B, Pauley C J, Niu Z, Denisova L, Follmer T T, Rizzuto G, Ciliberto G, Fattori E, Monica N L, Manam S, Ledwith B J, 2004: Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation[J]. Gene Ther, 11, 711-721. doi: 10.1038/sj.gt.3302213
-
Wolff J A, Malone R W, Williams P, Chong W, Acsadi G, Jani A, Felgner P L, 1990: Direct gene transfer into mouse muscle in vivo[J]. Science, 247, 1465-1468.
-
Xu J, Ren L, Huang X, Qiu C, Liu Y, Liu Y, Shao Y, 2006: Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes[J]. AIDS, 20, 2293-2303. doi: 10.1097/QAD.0b013e328010ad0c
-
Zhao K, Zhang Y H, Li H M. 1995. Medical Biology Product. (2nd ed.) People's Medical Publishing House, Beijing.